Table 1 Patients selection and patient characteristics
RARP BNP + PRec. n (%) | RARP(no BNP+ no PRec.) n (%) | Open RRP + BNP n(%) | Total n(%) | |
|---|---|---|---|---|
Selected patients | 105 | 125 | 62 | 292 |
Enrolled patients | 81 | 93 | 58 | 232 |
Age (median) ± SD | 69 ± 6.91 | 65.7 ± 6.5 | ||
BMI Kg/m2(median) ± SD | 26.31 ± 3.19 | 27.14 ± 2.40 | ||
Prostate volume | ||||
< 50 cm3 | 4 (5) | 18 (19.3) | 13 (22.4) | 35 (15) |
> 50 cm3 | 77 (95) | 75 (80.7) | 45 (77.6) | 197 (85) |
Phone call drop out -Pts deceased for unrelated causes | 24 (29.6) | 32 (34.4) | 4 (6.9) | 60 (25) |
3 | 2 | 1 | 6 | |
-Pts. who refused to respond the questionnaire or participate the visit | 21 | 30 | 3 | 54 |
Preoperative clinical data | n(%) | n(%) | n(%) | n(%) |
PSA <10 10–20 > 20 | 69(85.18) 12(14.81) 0 (0) | 67(72.04) 23(24.73) 3(3.3) | 42 (72.41) 13 (22.41) 3 (5.17) | 178 (76.72) 48 (20.68) 6 (2.58) |
Gleason score Low risk Intermediate risk High risk | 66 (81.48) 11 (13.58) 4 (4.93) | 68 (73.11) 18 (19.35) 7 (7.52) | 35 (60.34) 17 (29.31) 6 (10.34) | 169 (72.84) 46 (19.82) 17 (7.32) |
Postoperative pathological data | n(%) | n(%) | n(%) | n(%) |
Stage | ||||
T1-T2 T3 | 70 (86.41) 11 (13.58) | 69 (85.18) 24 (25.80) | 47 (81.03) 11 (18.96) | 186 (80.17) 46 (19.82) |
Gleason score | ||||
Low risk Intermediate risk High risk | 39 (48.14) 31 (38.27) 11 (13.58) | 41 (44.08) 38 (40.86) 14 (15.05) | 24 (41.37) 26 (44.82) 8 (13.79) | 104 (44.82) 95 (40.94) 33 (14.22) |